Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM

1998860 citationsJournal Article

Authors

Patrizio Tatti

Marco Pahor · University of Tennessee Health Science Center

Robert P. Byington · Wake Forest University

Patrizia Di Mauro

Riccardo Guarisco

G Strollo · Istituto Nazionale di Riposo e Cura per Anziani

Felice Strollo · Istituto Nazionale di Riposo e Cura per Anziani

Abstract

Fosinopril and amlodipine had similar effects on biochemical measures, but the patients randomized to fosinopril had a significantly lower risk of major vascular events, compared with the patients randomized to amlodipine.

Topics & Keywords

Blood Pressure and Hypertension Studies Pharmaceutical Practices and Patient Outcomes Electroconvulsive Therapy Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Care

Volume 21, Issue 4, pp. 597-603

DOI: 10.2337/diacare.21.4.597

Field-Weighted Citation Impact: 62.40